NACUITY PHARMACEUTICALS, INC. Trademark

Trademark Overview


On Tuesday, June 9, 2020, a trademark application was filed for NACUITY PHARMACEUTICALS, INC. with the United States Patent and Trademark Office. The USPTO has given the NACUITY PHARMACEUTICALS, INC. trademark a serial number of 88955986. The federal status of this trademark filing is REGISTERED as of Tuesday, March 23, 2021. This trademark is owned by Nacuity Pharmaceuticals, Inc.. The NACUITY PHARMACEUTICALS, INC. trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research in the fields of retinal-based and other ocular diseases and ophthalmological indications; providing a website featuring educational information in the field of clinical research and clinical trials; basic and clinical research in the field of treatments for ophthalmological indications, namely, retinitis pigmentosa
nacuity pharmaceuticals, inc.

General Information


Serial Number88955986
Word MarkNACUITY PHARMACEUTICALS, INC.
Filing DateTuesday, June 9, 2020
Status700 - REGISTERED
Status DateTuesday, March 23, 2021
Registration Number6298506
Registration DateTuesday, March 23, 2021
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 5, 2021

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"PHARMACEUTICALS, INC."
Description of MarkThe mark consists of the word "NACUITY" in large letters over "PHARMACEUTICALS, INC". in smaller letters next to a convex sphere comprised of different shaded or colored dots.
Goods and ServicesMedical and scientific research in the fields of retinal-based and other ocular diseases and ophthalmological indications; providing a website featuring educational information in the field of clinical research and clinical trials; basic and clinical research in the field of treatments for ophthalmological indications, namely, retinitis pigmentosa

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, July 4, 2020
Primary Code042
First Use Anywhere DateTuesday, January 31, 2017
First Use In Commerce DateTuesday, January 31, 2017

Trademark Owner History


Party NameNacuity Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressFort Worth, TX 76102

Party NameNacuity Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFort Worth, TX 76102

Party NameNacuity Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFort Worth, TX 76102

Trademark Events


Event DateEvent Description
Tuesday, March 23, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, January 5, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 5, 2021PUBLISHED FOR OPPOSITION
Wednesday, December 16, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, December 3, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 2, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 2, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 11, 2020PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Monday, November 30, 2020ASSIGNED TO LIE
Monday, September 14, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 14, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 14, 2020NON-FINAL ACTION E-MAILED
Monday, September 14, 2020NON-FINAL ACTION WRITTEN
Friday, September 11, 2020TEAS VOLUNTARY AMENDMENT RECEIVED
Friday, September 11, 2020ASSIGNED TO EXAMINER
Tuesday, July 7, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Saturday, July 4, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, June 12, 2020NEW APPLICATION ENTERED IN TRAM